$DLB

Dolby Laboratories, Inc.

Dolby develops audio and video technologies for content creators, distributors, consumer electronics manufacturers and cinema exhibitors. Its offerings include branded technologies such as Dolby Atmos, Dolby Vision, DD+ and Dolby AC-4, as well as patents for standardized audio and video codecs. Dolby Cinema combines Dolby Vision, Dolby Atmos and theater design, while its cinema products include servers, processors, amplifiers, loudspeakers and related software. Dolby OptiView is a software-as-a-service product for live-event engagement, especially sports. Dolby makes most of its money by licensing technology, its brand and patents to device manufacturers, including through per-unit royalties, minimum-volume commitments and patent pools. It also earns licensing revenue from Dolby Cinema box office receipts and sells or leases cinema products and provides related services to exhibitors. Dolby OptiView is licensed directly to enterprises on a consumption basis. Dolby is headquartered in San Francisco, California.

7
7
4

No SEC Form 4 filings for $DLB in the last 30 days.

See all $DLB insider activity →

Stocks making the biggest moves premarket: Nvidia, Take-Two Interactive, Lowe's & more

Dolby Laboratories' shares dropped 4% premarket after its revenue and earnings guidance for fiscal 2027 missed estimates. Multiple AI-related stocks rose following Nvidia's earnings beat. Target's shares slipped 1% despite strong sales growth and raised earnings guidance. Lowe's fell over 3% after reporting quarterly earnings that included tariff refunds.

Dolby Laboratories boost dividend by 8.3% to $0.39 a share

Dolby Laboratories (DLB) increased its quarterly dividend by 8.3% to $0.39 per share. The dividend is payable Dec. 9 to shareholders of record on Dec. 1, with an ex-dividend date of Dec. 1. The forward yield is 2.65%.

DLB sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 18 news stories mentioning DLB (Dolby Laboratories, Inc.). Coverage has skewed bullish: 7 bullish, 7 neutral, and 4 bearish.

Recent DLB coverage spans earnings, financial news and corporate actions.

What's driving DLB

  • A bearish adjustment to the analyst price target can modestly pressure near-term sentiment, though the rating remains Buy.

    tradingview.com · Nov 18, 2026

  • Guidance miss likely keeps downside pressure as traders reprice FY and near-term revenue expectations.

    cnbc.com · Nov 18, 2026

  • Dividend hike supports a modestly positive income narrative, but it is unlikely to drive a large repricing absent other fundamentals.

    seekingalpha.com · Nov 18, 2026

  • Guidance and capital return (dividend plus buyback) likely support the stock, while GAAP EPS range implies near-term earnings volatility.

    prnewswire.com · Nov 17, 2026

  • The new bonus and severance terms could modestly affect compensation expense and shareholder perception, but no immediate financial impact is quantified.

    SEC EDGAR 8-K · Nov 13, 2026

AlphAI scores every news story that mentions DLB with an AI model for sentiment and relevance, and aggregates insider trades from Dolby Laboratories, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $DLB

Score

Dolby Laboratories, Inc. (DLB): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Approval of 2027 Dolby Executive Bonus Plan On November 10, 2026, the Compensation Committee (the “Committee”) of the Board

Related tickers